AbbVie ABBV
NYSE ABBV
$288.21 -6.69 (-2.27%)
At close: Nov 5, 2026 · 4:00 PM EST

AbbVie (ABBV) Income After Tax (2012 - 2026)

Updated

AbbVie (ABBV) recorded Income After Tax of $4.22 billion in Q3 2026, compared with $188 million a year earlier and up 16.7% from the prior quarter.

Analysis

AbbVie (ABBV) Income After Tax (2012 - 2026) Analysis & Trends

On a TTM basis, AbbVie's Income After Tax came in at $10.35 billion as of Sep 30, 2026, up 332.1% year-over-year; for FY2025, it came in at $4.23 billion, down 1.2% from FY2024.

  • Annual Income After Tax has declined for three straight years, with a five-year compound annual growth rate of -1.7% (FY2020 to FY2025).
  • Across earlier years, Income After Tax came in at $4.29 billion in FY2024 (-12.0%), $4.87 billion in FY2023 (-58.9%), $11.85 billion in FY2022 (+2.6%) and $11.55 billion in FY2021 (+149.9%).
  • The Q3 2026 figure is the highest quarterly Income After Tax since Q1 2022.
  • On a year-over-year basis, Income After Tax rose in 1 of the last five quarters, with growth averaging 22.6%.
  • Peak year-over-year performance for Income After Tax in the last five years was growth of 284.3% in Q2 2026, against a decline of 89.4% in Q1 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.62 billion (Q2 2026), $697 million (Q1 2026) and $1.82 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income After Tax (Qtr)
1 Eli Lilly 1,286.35 Bn 1,259.96 Bn 20.46 Bn 6.45 Bn
2 Johnson & Johnson 655.58 Bn 575.44 Bn 17.30 Bn 210.00 Mn
3 AbbVie 509.44 Bn 477.50 Bn 13.12 Bn 4.22 Bn
4 Merck 362.14 Bn 325.14 Bn 13.19 Bn 5.07 Bn
5 Novartis Ag 309.04 Bn 282.62 Bn - -
6 Astrazeneca 289.57 Bn 263.55 Bn 13.26 Bn 4.80 Bn
7 Amgen 248.97 Bn 200.62 Bn 7.58 Bn 3.86 Bn
8 Gilead Sciences 207.95 Bn 182.98 Bn 6.73 Bn 2.43 Bn
9 Pfizer 170.25 Bn 117.91 Bn 12.56 Bn 3.25 Bn
10 Vertex Pharmaceuticals 137.54 Bn 109.53 Bn 2.91 Bn 653.60 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.22 Bn
Jun 30, 2026 3.62 Bn
Mar 31, 2026 697.00 Mn
Dec 31, 2025 1.82 Bn
Sep 30, 2025 188.00 Mn
Jun 30, 2025 941.00 Mn
Mar 31, 2025 1.29 Bn
Dec 31, 2024 -23.00 Mn
Sep 30, 2024 1.56 Bn
Jun 30, 2024 1.37 Bn
Mar 31, 2024 1.37 Bn
Dec 31, 2023 824.00 Mn
Sep 30, 2023 1.78 Bn
Jun 30, 2023 2.03 Bn
Mar 31, 2023 475.00 Mn
Dec 31, 2022 2.47 Bn
Sep 30, 2022 3.95 Bn
Jun 30, 2022 928.00 Mn
Mar 31, 2022 4.49 Bn
Dec 31, 2021 4.05 Bn
API Access

AbbVie Income After Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=profit-after-tax&ticker=ABBV&period=max&api_key=YOUR_API_KEY